{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:07:02Z","timestamp":1782122822892,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00001\/2"],"award-info":[{"award-number":["MC_UU_00001\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejca.2019.12.022","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T02:29:48Z","timestamp":1583720988000},"page":"7-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes"],"prefix":"10.1016","volume":"128","author":[{"given":"A.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Drinkwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"McParland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Glynne-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sebag-Montefiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Muirhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejca.2019.12.022_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Canc"},{"issue":"6","key":"10.1016\/j.ejca.2019.12.022_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.12.022_bib3","series-title":"Radiotherapy in england","author":"Department of Health Cancer Policy Team","year":"2012"},{"issue":"6","key":"10.1016\/j.ejca.2019.12.022_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ejca.2019.12.022_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.clon.2014.08.001","article-title":"Anal cancer: developing an intensity-modulated radiotherapy solution for ACT2 fractionation","volume":"26","author":"Muirhead","year":"2014","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2019.12.022_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clon.2016.10.005","article-title":"Initial results from the royal College of Radiologists' UK national audit of anal cancer radiotherapy 2015","volume":"29","author":"Muirhead","year":"2017","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2019.12.022_bib7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ijrobp.2018.04.033","article-title":"Toxicity, tolerability, and compliance of concurrent capecitabine or 5-fluorouracil in radical management of anal cancer with single-dose mitomycin-C and intensity modulated radiation therapy: evaluation of a national cohort","volume":"101","author":"Jones","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2019.12.022_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2019.12.022_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2014.06.061","article-title":"Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer","volume":"90","author":"Han","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.radonc.2015.08.008","article-title":"Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer","volume":"117","author":"Joseph","year":"2015","journal-title":"Radiother Oncol: Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"29","key":"10.1016\/j.ejca.2019.12.022_bib11","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience","volume":"25","author":"Salama","year":"2007","journal-title":"J Clin Oncol: Official Journal of the American Society of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.ejca.2019.12.022_bib12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.24906","article-title":"Long-term quality of life after radiotherapy for the treatment of anal cancer","volume":"116","author":"Das","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2019.12.022_bib13","first-page":"3613","article-title":"Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy","volume":"23","author":"Sodergren","year":"2015","journal-title":"Support Care Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"key":"10.1016\/j.ejca.2019.12.022_bib14","series-title":"Terminology criteria for adverse events (CTCAE)","author":"Common","year":"2009"},{"issue":"17","key":"10.1016\/j.ejca.2019.12.022_bib15","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ejca.2009.08.014","article-title":"Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer","volume":"45","author":"Whistance","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2019.12.022_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2017.11.018","article-title":"Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. Radiotherapy and oncology","volume":"126","author":"Sodergren","year":"2018","journal-title":"Journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.ejca.2019.12.022_bib18","series-title":"Stata statistical software: release 13.1","author":"StataCorp","year":"2013"},{"issue":"12","key":"10.1016\/j.ejca.2019.12.022_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2468-1253(18)30264-4","article-title":"A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus","volume":"3","author":"Fish","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2019.12.022_bib20","series-title":"EORTC QLQ-C30 scoring manual","author":"Fayers","year":"1999"},{"issue":"1","key":"10.1016\/j.ejca.2019.12.022_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol: Official Journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib22","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1016\/j.ijrobp.2016.06.1006","article-title":"The development of an umbrella trial (PLATO) to address radiation therapy dose questions in the locoregional management of squamous cell carcinoma of the anus","volume":"96","author":"Sebag-Montefiore","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11136-018-2020-3","article-title":"Making a picture worth a thousand numbers: recommendations for graphically displaying patient-reported outcomes data","volume":"28","author":"Snyder","year":"2019","journal-title":"Qual Life Res: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation"},{"issue":"1","key":"10.1016\/j.ejca.2019.12.022_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":"Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2019.12.022_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2012.04.018","article-title":"Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer","volume":"103","author":"Barraclough","year":"2012","journal-title":"Radiother Oncol : Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.radonc.2016.06.020","article-title":"Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer","volume":"120","author":"Joseph","year":"2016","journal-title":"Radiother Oncol: Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"8","key":"10.1016\/j.ejca.2019.12.022_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clon.2004.05.007","article-title":"Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors","volume":"16","author":"Jephcott","year":"2004","journal-title":"Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2019.12.022_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00066-010-2175-5","article-title":"Quality of life outcomes in patients with anal cancer after combined radiochemotherapy","volume":"187","author":"Welzel","year":"2011","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.ejca.2019.12.022_bib30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","article-title":"Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors","volume":"52","author":"Bentzen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2019.12.022_bib31","first-page":"41","article-title":"Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma","volume":"5","author":"Provencher","year":"2010","journal-title":"Radiata"},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2017.02.005","article-title":"Predictors of radiation therapy-related gastrointestinal toxicity from anal cancer dose-painted intensity modulated radiation therapy: secondary analysis of NRG oncology RTOG 0529","volume":"98","author":"Olsen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2019.12.022_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00066-010-2175-5","article-title":"Quality of life outcomes in patients with anal cancer after combined radiochemotherapy","volume":"187","author":"Welzel","year":"2011","journal-title":"Strahlenther Onkol: Organ der Deutschen Rontgengesellschaft [et\u00a0al]"},{"issue":"3","key":"10.1016\/j.ejca.2019.12.022_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2015.02.029","article-title":"Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2019.12.022_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2015.06.011","article-title":"Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial","volume":"116","author":"Yahya","year":"2015","journal-title":"Radiother Oncol: Journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.ejca.2019.12.022_bib36","unstructured":"ISRCTN Registry. PLATO - personalising anal cancer radiotherapy dose. ISRCTN88455282 https:\/\/doi.org\/10.1186\/ISRCTN88455282. (Accessed 13 March 2019 at http:\/\/www.isrctn.com\/ISRCTN88455282q=&filters=conditionCategory:Cancer&sort=&offset=9&totalResults=1850&page=1&pageSize=10&searchType=basic-search)."},{"issue":"2","key":"10.1016\/j.ejca.2019.12.022_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clon.2018.10.010","article-title":"Anal cancer: putting health-related quality of life at the forefront","volume":"31","author":"Sodergren","year":"2019","journal-title":"Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919308901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919308901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:26:17Z","timestamp":1760732777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919308901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"alternative-id":["S0959804919308901"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.12.022","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}